Lilly launches Tanstrive (Selpercatinib), a RET inhibitor to treat advanced cancers with RET gene alteration Read more
Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical risks: GlobalData Read more
U.S. FDA approves Eli Lilly’s single-injection, once-monthly Omvoh regimen for adults with ulcerative colitis Read more
Lilly’s orforglipron and other key catalysts can reshape drug landscape in Q3 2025: GlobalData Read more
ATMF report reveals that insulin remains out of reach for T1D patients in LMICs, children facing gross inequities Read more